ATE135348T1 - Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie - Google Patents

Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie

Info

Publication number
ATE135348T1
ATE135348T1 AT92401772T AT92401772T ATE135348T1 AT E135348 T1 ATE135348 T1 AT E135348T1 AT 92401772 T AT92401772 T AT 92401772T AT 92401772 T AT92401772 T AT 92401772T AT E135348 T1 ATE135348 T1 AT E135348T1
Authority
AT
Austria
Prior art keywords
pyrimidine
therapy
preparation
carboxamide derivatives
hydrogen atom
Prior art date
Application number
AT92401772T
Other languages
English (en)
Inventor
Pascal George
Jacques Froissant
Arlette Tixidre
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE135348T1 publication Critical patent/ATE135348T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92401772T 1991-06-27 1992-06-24 Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie ATE135348T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9107937A FR2678271B1 (fr) 1991-06-27 1991-06-27 Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ATE135348T1 true ATE135348T1 (de) 1996-03-15

Family

ID=9414357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92401772T ATE135348T1 (de) 1991-06-27 1992-06-24 Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie

Country Status (21)

Country Link
US (1) US5244901A (de)
EP (1) EP0522915B1 (de)
JP (1) JP3160371B2 (de)
KR (1) KR930000509A (de)
CN (1) CN1067884A (de)
AT (1) ATE135348T1 (de)
AU (1) AU645698B2 (de)
CA (1) CA2072528A1 (de)
CZ (1) CZ9202002A3 (de)
DE (1) DE69208955T2 (de)
DK (1) DK0522915T3 (de)
ES (1) ES2087477T3 (de)
FI (1) FI922983L (de)
FR (1) FR2678271B1 (de)
GR (1) GR3020055T3 (de)
HU (1) HUT61996A (de)
IE (1) IE922093A1 (de)
MX (1) MX9203331A (de)
NO (1) NO922524L (de)
PL (1) PL295021A1 (de)
ZA (1) ZA924787B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678272B1 (fr) * 1991-06-27 1994-01-14 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
ATE123025T1 (de) * 1992-07-03 1995-06-15 Synthelabo 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
US5447916A (en) * 1993-07-30 1995-09-05 Chiron Corporation Peptoid alpha-1 adrenergic receptor ligands
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
CN101353313A (zh) 1997-11-07 2009-01-28 法玛西雅厄普约翰美国公司 制备唑烷酮的方法
EP1346983A3 (de) * 1998-02-20 2003-12-03 Ortho-Mcneil Pharmaceutical, Inc. Phthalimido-arylpiperazine als alpha 1A Rezeptor Antagonisten nützlich zur Behandlung von gutartiger Prostatahyperplasie
ZA991319B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
TW536538B (en) 1998-02-20 2003-06-11 Ortho Mcneil Pharm Inc Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU3883099A (en) * 1998-05-06 1999-11-23 Duke University Method of treating bladder and lower urinary tract syndromes
JP3519302B2 (ja) 1999-02-09 2004-04-12 株式会社東海理化電機製作所 ウエビング巻取装置用プリテンショナー
KR100566189B1 (ko) * 1999-12-29 2006-03-29 동화약품공업주식회사 신규의 5-피리미딘카르복스아미드 유도체 및 그를포함하는 약학적 조성물
KR100566188B1 (ko) * 1999-11-27 2006-03-29 동화약품공업주식회사 신규의 5-피리미딘카르복스아미드 유도체 및 그를포함하는 약학적 조성물
AU2003250490A1 (en) 2002-08-23 2004-03-11 Pfizer Products Inc. Apparatus for dispensing articles
US20060276465A1 (en) * 2003-12-26 2006-12-07 Eisai R&D Management Co., Ltd. 1,2-di(cyclic) substituted benzene compounds
CN100526301C (zh) * 2003-12-26 2009-08-12 卫材R&D管理有限公司 1,2-二(环式基)取代苯化合物
US7410971B2 (en) 2003-12-26 2008-08-12 Eisai R&D Management Co., Ltd. 1,2-di(cyclic)substituted benzene compounds
MY140489A (en) 2003-12-26 2009-12-31 Eisai R&D Man Co Ltd 1,2-di (cyclic) substituted benzene compounds
US20090312344A1 (en) * 2004-05-31 2009-12-17 Mohammad Salman Arylpiperazine derivatives as adrenergic receptor antagonists
SE0402200D0 (sv) * 2004-09-13 2004-09-13 Astrazeneca Ab New process II
KR101274879B1 (ko) 2004-12-20 2013-06-14 에자이 알앤드디 매니지먼트 가부시키가이샤 1-시클로프로필메틸-4-[2-(3,3,5,5-테트라메틸시클로헥실)페닐]피페라진의 염 및 결정
US20090163715A1 (en) * 2005-05-25 2009-06-25 Eisai R&D Management Co., Ltd. Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound
MY144974A (en) * 2005-06-14 2011-11-30 Eisai R&D Man Co Ltd 1,2-di(cyclic) substituted benzene derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143730A (en) * 1932-05-27 1939-01-10 Apex Electrical Mfg Co Clothes washer
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel
FR2618436B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
FR2620121B1 (fr) * 1987-09-09 1990-01-05 Synthelabo ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
AU1859092A (en) 1993-01-07
KR930000509A (ko) 1993-01-15
FI922983A7 (fi) 1992-12-28
FI922983A0 (fi) 1992-06-26
DK0522915T3 (da) 1996-07-22
HUT61996A (en) 1993-03-29
JP3160371B2 (ja) 2001-04-25
ES2087477T3 (es) 1996-07-16
CZ9202002A3 (en) 1993-01-13
DE69208955T2 (de) 1996-10-24
IE922093A1 (en) 1992-12-30
US5244901A (en) 1993-09-14
EP0522915A1 (de) 1993-01-13
HU9202137D0 (en) 1992-10-28
FR2678271B1 (fr) 1995-01-13
GR3020055T3 (en) 1996-08-31
JPH05186434A (ja) 1993-07-27
EP0522915B1 (de) 1996-03-13
MX9203331A (es) 1992-12-01
ZA924787B (en) 1993-03-31
AU645698B2 (en) 1994-01-20
FR2678271A1 (fr) 1992-12-31
DE69208955D1 (de) 1996-04-18
CA2072528A1 (en) 1992-12-28
CN1067884A (zh) 1993-01-13
FI922983L (fi) 1992-12-28
NO922524D0 (no) 1992-06-26
PL295021A1 (en) 1993-03-08
NO922524L (no) 1992-12-28

Similar Documents

Publication Publication Date Title
ATE135348T1 (de) Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie
IL96815A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapeutics
ATE82969T1 (de) 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion 2,4-derivate, deren herstellung und verwendung als heilmittel.
DE69410509D1 (de) Benzoxazinderivate, deren Herstellung und deren Verwendung in Therapie
DK0515540T3 (da) Derivat af beta-phenylisoserin, dets fremstilling og anvendelse
ATE117552T1 (de) Verwendung von thiazoloisoindolinon-derivaten als antivirale arzneimittel.
DK0520882T3 (da) Derivater af 2-aminopyrimidin-4-carboxamid, deres fremstilling og deres terapeutiske anvendelse
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
DK0577470T3 (da) 2-amino-N(((4-(aminocarbonyl)pyrimidin-2-yl)amino)alkyl) pyrimidin-4-carboxamid-derivater, deres fremstilling og deres anvendelse i terapi
DK0483063T3 (da) Ergolinderivater
ES483557A1 (es) Procedimiento para la preparacion de derivados de imidazol
KR920019728A (ko) 아세토구아나민형 및 시클로헥실구아나민형 화합물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee